E-LIB Suche - Ergebnisse für: Fritsch, Sandor

1

Response to the Letter to the Editor Regarding "Assessment ..:

Suez, Daniel ; Stein, Mark ; Gupta, Sudhir...
Journal of Clinical Immunology. 37 (2017) 8 - p. 739-740 , 2017

Link: https://doi.org/10.1007/..

2

A phase 3 trial of IV immunoglobulin for Alzheimer disease:

Relkin, Norman R. ; Thomas, Ronald G. ; Rissman, Robert A....
Neurology. 88 (2017) 18 - p. 1768-1775 , 2017

Link: https://doi.org/10.1212/..

3

Efficacy, Safety, Tolerability, and Pharmacokinetics of Hum..:

Suez, Daniel ; Melamed, Isaac ; Hussain, Iftikhar...
Journal of Allergy and Clinical Immunology. 137 (2016) 2 - p. AB221 , 2016

Link: https://doi.org/10.1016/..

4

Efficacy, Safety, and Pharmacokinetics of a Novel Human Imm..:

Suez, Daniel ; Stein, Mark ; Gupta, Sudhir...
Journal of Clinical Immunology. 36 (2016) 7 - p. 700-712 , 2016

Link: https://doi.org/10.1007/..

5

Demonstration of safety of intravenous immunoglobulin in ge..:

Gelmont, David ; Thomas, Ronald G. ; Britt, Jonathan...
Alzheimer's & Dementia: Translational Research & Clinical Interventions. 2 (2016) 2 - p. 131-139 , 2016

Link: https://doi.org/10.1016/..

6

Safety and Immunogenicity of a Vero Cell Culture-Derived Wh..:

van der Velden, Maikel V. W. ; Fritz, Richard ; Pöllabauer, Eva Maria...
The Journal of Infectious Diseases. 209 (2014) 1 - p. 12-23 , 2014

Link: http://www.jstor.org/sta..

7

Single priming dose of meningococcal group C conjugate vacc..:

Poellabauer, Eva-Maria ; Pavlova, Borislava G. ; Fritsch, Sandor...
Vaccine. 31 (2013) 35 - p. 3611-3616 , 2013

Link: https://doi.org/10.1016/..

8

Cell culture (Vero cell) derived whole-virus non-adjuvanted..:

van der Velden, Maikel V.W. ; Aichinger, Gerald ; Pöllabauer, Eva Maria...
Vaccine. 30 (2012) 43 - p. 6127-6135 , 2012

Link: https://doi.org/10.1016/..

9

Pre-vaccination immunity and immune responses to a cell cul..:

Ehrlich, Hartmut J. ; Müller, Markus ; Kollaritsch, Herwig...
Vaccine. 30 (2012) 30 - p. 4543-4551 , 2012

Link: https://doi.org/10.1016/..

10

Safety and immunogenicity of two different doses of a Vero ..:

Tambyah, Paul A. ; Wilder-Smith, Annelies ; Pavlova, Borislava G....
Vaccine. 30 (2012) 2 - p. 329-335 , 2012

Link: https://doi.org/10.1016/..

11

Clinical development of a Vero cell culture-derived seasona..:

Ehrlich, Hartmut J. ; Berezuk, Gregory ; Fritsch, Sandor...
Vaccine. 30 (2012) 29 - p. 4377-4386 , 2012

Link: https://doi.org/10.1016/..

12

A Cell Culture—Derived Influenza Vaccine Provides Consisten..:

Ehrlich, Hartmut J. ; Singer, Julia ; Berezuk, Gregory...
Clinical Infectious Diseases. 54 (2012) 7 - p. 946-954 , 2012

Link: https://www.jstor.org/st..

13

A non-adjuvanted whole-virus H1N1 pandemic vaccine is well ..:

Loew-Baselli, Alexandra ; Pavlova, Borislava G. ; Fritsch, Sandor...
Vaccine. 30 (2012) 41 - p. 5956-5966 , 2012

Link: https://doi.org/10.1016/..

14

Safety and immunogenicity of an inactivated whole virus Ver..:

Aichinger, Gerald ; Ehrlich, Hartmut J. ; Aaskov, John G....
Vaccine. 29 (2011) 50 - p. 9376-9384 , 2011

Link: https://doi.org/10.1016/..

15

Prevention of tick-borne encephalitis by FSME-IMMUN® vaccin..:

Loew-Baselli, Alexandra ; Poellabauer, Eva Maria ; Pavlova, Borislava G....
Vaccine. 29 (2011) 43 - p. 7307-7319 , 2011

Link: https://doi.org/10.1016/..